The Cancer Prevention and Research Institute of Texas (CPRIT) has recently awarded the Simmons Cancer Center with about $19 million cancer research funding. Of these funds, Raquibul Hannan, M.D., Ph.D and his Kidney Cancer Program investigation team were awarded about $2 million. Dr. Hannan serves as a professor of Radiation Oncology and Immunology and Urology, as well as the Chief of Genitourinary Radiation Oncology Service. These funds will go toward a clinical trial aimed at investigating the impact of stereotactic ablative body radiotherapy on metastatic kidney cancer. This clinical trial is also supported by the Kidney Cancer SPORE grant.
See UTSW’s article for more information on the award.
